Your browser doesn't support javascript.
loading
A risk-stratified therapy for infants with acute lymphoblastic leukemia: a report from the JPLSG MLL-10 trial.
Tomizawa, Daisuke; Miyamura, Takako; Imamura, Toshihiko; Watanabe, Tomoyuki; Moriya Saito, Akiko; Ogawa, Atsushi; Takahashi, Yoshihiro; Hirayama, Masahiro; Taki, Tomohiko; Deguchi, Takao; Hori, Toshinori; Sanada, Masashi; Ohmori, Shigeru; Haba, Masami; Iguchi, Akihiro; Arakawa, Yuki; Koga, Yuhki; Manabe, Atsushi; Horibe, Keizo; Ishii, Eiichi; Koh, Katsuyoshi.
Afiliação
  • Tomizawa D; Division of Leukemia and Lymphoma, Children's Cancer Center, National Center for Child Health and Development, Tokyo, Japan.
  • Miyamura T; Department of Pediatrics, Osaka University Graduate School of Medicine, Suita, Japan.
  • Imamura T; Department of Pediatrics, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan.
  • Watanabe T; Department of Nutritional Science, Faculty of Psychological and Physical Science, Aichi Gakuin University, Nisshin, Japan.
  • Moriya Saito A; Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
  • Ogawa A; Department of Pediatrics, Niigata Cancer Center Hospital, Niigata, Japan.
  • Takahashi Y; Department of Pediatrics, Aomori Prefectural Central Hospital, Aomori, Japan.
  • Hirayama M; Department of Pediatrics, Mie University Graduate School of Medicine, Tsu, Japan.
  • Taki T; Department of Medical Technology, Kyorin University Faculty of Health Sciences, Tokyo, Japan.
  • Deguchi T; Department of Pediatrics, Mie University Graduate School of Medicine, Tsu, Japan.
  • Hori T; Division of Cancer Immunodiagnostics, Children's Cancer Center, National Center for Child Health and Development, Tokyo, Japan.
  • Sanada M; Department of Pediatrics, Aichi Medical University, Nagakute, Japan.
  • Ohmori S; Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
  • Haba M; Department of Pharmacy, Shinshu University Hospital, Matsumoto, Japan.
  • Iguchi A; Department of Pharmacy, Faculty of Pharmacy, Chiba Institute of Science, Choshi, Japan.
  • Arakawa Y; Department of Pediatrics, Hokkaido University, Sapporo, Japan.
  • Koga Y; Department of Hematology/Oncology, Saitama Children's Medical Center, Saitama, Japan.
  • Manabe A; Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan; and.
  • Horibe K; Department of Pediatrics, Hokkaido University, Sapporo, Japan.
  • Ishii E; Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
  • Koh K; Department of Pediatrics, Ehime University Graduate School of Medicine, Toon, Japan.
Blood ; 136(16): 1813-1823, 2020 10 15.
Article em En | MEDLINE | ID: mdl-32845001
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Infant / Male País/Região como assunto: Asia Idioma: En Revista: Blood Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Japão
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Infant / Male País/Região como assunto: Asia Idioma: En Revista: Blood Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Japão